Hap Trading, LLC Acelrx Pharmaceuticals Inc Put Options Transaction History

Hap Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 12, 2022	SELL	$0.28 - $0.61 $28 - $61	-100 Reduced 0.9%	11,000 $23,000
Q4 2021 Feb 14, 2022	BUY	$0.49 - $1.02 $5,439 - $11,322	11,100 New	11,100 $22,000
Q2 2020 Aug 10, 2020	SELL	$1.03 - $1.69 $28,428 - $46,644	-27,600 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$0.76 - $2.07 $5,244 - $14,282	6,900 Added 33.33%	27,600 $36,000
Q4 2019 Feb 11, 2020	BUY	$1.66 - $2.4 $34,362 - $49,680	20,700 New	20,700 $15,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.